Can't see evidence of much selling through Taylor Collison, Lexcorp, but I can see signs of buying by key TC institutional clients and others such as:
. C2 Ventures, controlled by CDX directors Craig Cooper and Niall Cairns
. $CVC/Safari Capital
. SG Hiscock
. Australian Executor Trustees
. A/Prof Paul Cozzi, Sydney urologist
. Campbell Kitchener Hume & Associates
. Drumnadrochit Futures and
. Ponderosa Investments, controlled by former WA stockbroker Jon Fogarty a Warren Buffet disciple who describes himself as being "one of Australia's leading healthcare and technology investors".
CDX Price at posting:
3.5¢ Sentiment: None Disclosure: Held
